Less Ads, More Data, More Tools Register for FREE

Pin to quick picksApax Global Alpha Regulatory News (APAX)

  • This share is currently suspended. It was suspended at a price of 164.40
  • There is currently no data for APAX

Form 8.5 (EPT/RI)

11 Sep 2025 11:41

RNS Number : 9955Y
Winterflood Securities Limited
11 September 2025
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Winterflood Securities Ltd

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

APAX Global Alpha Ltd

(c) Name of the party to the offer with which exempt principal trader is connected:

APAX Global Alpha Ltd

(d) Date dealing undertaken:

10/09/2025

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

APAX Global Alpha Ltd

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Ordinary shares

Purchases

1,500

1.63 GBP

1.63 GBP

Ordinary shares

Sales

-

-

-

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

NIL

NIL

NIL

NIL

NIL

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

NIL

NIL

NIL

NIL

NIL

NIL

NIL

NIL

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

NIL

NIL

NIL

NIL

NIL

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

NIL

NIL

 

NIL

NIL

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

Date of disclosure:

11/09/2025

Contact name:

Alex Giacopazzi

Telephone number:

020 3100 0427

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERDZGMLGMGGKZM
Date   Source Headline
26th Mar 20201:12 pmRNSStatement regarding COVID-19
20th Mar 20204:46 pmRNSSecond Price Monitoring Extn
20th Mar 20204:36 pmRNSPrice Monitoring Extension
20th Mar 202010:20 amRNSSecond Price Monitoring Extn
20th Mar 202010:16 amRNSPrice Monitoring Extension
19th Mar 202012:07 pmRNSSecond Price Monitoring Extn
19th Mar 202012:02 pmRNSPrice Monitoring Extension
17th Mar 20204:00 pmRNSDirector/PDMR Shareholding
17th Mar 20204:00 pmRNSDirector/PDMR Shareholding
13th Mar 202012:07 pmRNSSecond Price Monitoring Extn
13th Mar 202012:02 pmRNSPrice Monitoring Extension
12th Mar 202012:07 pmRNSSecond Price Monitoring Extn
12th Mar 202012:02 pmRNSPrice Monitoring Extension
11th Mar 20207:00 amRNSDirector/PDMR Shareholding
9th Mar 20207:00 amRNSNotice of Results
5th Mar 20202:17 pmRNSPurchase of Ordinary Shares under IM Agreement
5th Mar 20207:00 amRNSNotice of Investor Day
3rd Mar 202012:02 pmRNSPrice Monitoring Extension
3rd Mar 20207:00 amRNSUpdated Key Information Document
3rd Mar 20207:00 amRNSNotice of AGM
3rd Mar 20207:00 amRNS2019 Annual Dividend
3rd Mar 20207:00 amRNS2019 Final Results
3rd Mar 20207:00 amRNS2019 Annual Report and Accounts
14th Feb 20207:00 amRNSDirector Change - Appointment
4th Feb 20207:00 amRNSApax Funds' Valuations as at 31 December 2019
15th Jan 20203:31 pmRNSPDMR Shareholding
15th Jan 20203:30 pmRNSPDMR Shareholding
26th Nov 20194:35 pmRNSPrice Monitoring Extension
11th Nov 20197:00 amRNSNotice of Annual Results
6th Nov 20197:00 amRNSQuarterly Results for 30 September 2019
16th Oct 20197:00 amRNSApax Funds' Valuations as at 30 September 2019
27th Sep 20194:40 pmRNSSecond Price Monitoring Extn
27th Sep 20194:35 pmRNSPrice Monitoring Extension
16th Sep 201910:37 amRNSNotice of Quarterly Results - September 2019
20th Aug 20199:17 amRNSPDMR Dealing - Share Transfers
14th Aug 20197:00 amRNS2019 Interim Dividend
14th Aug 20197:00 amRNS2019 Interim Results Highlights
14th Aug 20197:00 amRNS2019 Interim Report and Accounts
1st Aug 20197:00 amRNSApax Digital Fund Valuation as at 30 June 2019
30th Jul 20197:00 amRNSApax Funds' Valuations as at 30 June 2019
15th Jul 201910:59 amRNSProposed commitment to the Apax X Fund
22nd May 20197:00 amRNSAGA Investor Day
17th May 20194:30 pmRNSDirector/PDMR Shareholding
9th May 20197:00 amRNSNotice of Interim Results - June 2019
8th May 201912:28 pmRNSResult of AGM Replacement
8th May 20197:00 amRNSQuarterly Results for 31 March 2019
7th May 20196:30 pmRNSResult of AGM
5th Apr 20195:32 pmRNSApax Funds' Valuations as at 31 March 2019
19th Mar 20192:39 pmRNSNotice of Investor Day
18th Mar 20199:59 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.